Avivagen Profile

0.70
CAD 0.06  9.38%
100%
0%

Avivagen Summary

Avivagen (VIV) is traded on TSX Venture Exchange in Canada. It is located in 100 Sussex Drive and employs 19 people. The company currently falls under 'Micro-Cap' category with current market capitalization of 23.5 M. Avivagen has 33.57 M outstanding shares of which 0 shares are at this time shorted by private and institutional investors with about 0.0 days to cover all short positions. AVIVAGEN INC has accumulated about 4.13 M in cash with (5.02 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.12.
Check Avivagen Probability Of Bankruptcy

Target Price Odds Analysis

Odds Below 0.7HorizonTargetOdds Above 0.7
?%30 days 0.70 ?%
Based on normal probability distribution, the odds of Avivagen to move above current price in 30 days from now is about 0.0% (This Avivagen probability density function shows the probability of Avivagen Stock to fall within a particular range of prices over 30 days) .

Key Fundamentals

Avivagen Against Markets

Current Ratings

Avivagen 30 Days Performance Scores
Risk Adjusted
Performance Score (0 to 100)
8 
Chance of
Financial Distress (0 to 100%)
21 
Equity ratings for Avivagen are calculated dynamically based on Macroaxis scoring framework. Click here to learn more
Avivagen, Inc. develops and commercializes various products to replace antibiotics in livestock feeds to optimize the health and growth of the animals by supporting the animals own health defenses. The company was formerly known as Chemaphor, Inc. and changed its name to Avivagen, Inc. in May 2012. Avivagen is traded on TSX Venture Exchange in Canada. more
NameAvivagen
CEO and President and DirectorCameron GroomeView All
Macroaxis Advice
InstrumentCanada Stock View All
Business Address100 Sussex Drive
Foreign Associate  USA
ExchangeTSX Venture Exchange
SectorHealthcare
BenchmarkDOW
Websitewww.avivagen.com
Contact Number613 949 8164
CurrencyCAD - Canadian Dollar

Current Sentiment - VIV

Avivagen Investor Sentiment
Most of Macroaxis users are at this time bullish on Avivagen. What is your sentiment towards investing in Avivagen? Are you bullish or bearish?
Bullish
Bearish
98% Bullish
2% Bearish
Skip

Diversify with Avivagen

Build Optimal Portfolios
Fix your portfolio
By capturing your risk tolerance and investment horizon Macroaxis technology of instant portfolio optimization will compute exactly how much risk is acceptable for your desired return expectations when you add Avivagen to your portfolio

Directors

Avivagen Corporate Directors
David Hankinson Executive Director
Louis Hui Director - Business Development
David Allan Director
Also please take a look at World Market Map. Please also try Correlation Analysis module to reduce portfolio risk simply by holding instruments which are not perfectly correlated.